Drug Shortage Report for LOVENOX
Report ID | 138203 |
Drug Identification Number | 02378434 |
Brand name | LOVENOX |
Common or Proper name | Lovenox |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ENOXAPARIN SODIUM |
Strength(s) | 80MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 10 |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-12-08 |
Actual start date | 2021-12-02 |
Estimated end date | 2021-12-22 |
Actual end date | 2021-12-21 |
Shortage status | Resolved |
Updated date | 2022-01-06 |
Company comments | Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v33 | 2022-01-06 | French | Compare |
v32 | 2022-01-06 | English | Compare |
v31 | 2021-12-17 | French | Compare |
v30 | 2021-12-17 | English | Compare |
v29 | 2021-12-03 | English | Compare |
v28 | 2021-12-02 | French | Compare |
v27 | 2021-12-02 | English | Compare |
v26 | 2021-11-23 | French | Compare |
v25 | 2021-11-23 | English | Compare |
v24 | 2021-11-20 | English | Compare |
v23 | 2021-11-10 | French | Compare |
v22 | 2021-11-10 | English | Compare |
v21 | 2021-10-05 | French | Compare |
v20 | 2021-10-05 | English | Compare |
v19 | 2021-09-30 | French | Compare |
v18 | 2021-09-30 | English | Compare |
v17 | 2021-09-08 | English | Compare |
v16 | 2021-08-31 | French | Compare |
v15 | 2021-08-31 | English | Compare |
v14 | 2021-08-24 | French | Compare |